Patients who previously failed treatment with lenvatinib monotherapy showed a renewed response when the drug was paired with the novel experimental agent E7386. This breakthrough in gynecologic oncology represents a turning point for patients facing advanced endometrial cancer after exhausting
The upcoming appellate verdict for Kang will address specific charges of submitting fraudulent animal testing data to the Ministry of Food and Drug Safety for a potential antiviral drug. This legal proceeding serves as a critical juncture for the South Korean pharmaceutical industry, highlighting
Pharma developers must reconcile their mathematical models with biological reality to ensure that effective treatments for systemic lupus are not sidelined by outdated trial designs. The recent clinical development of enpatoran, a highly anticipated first-in-class treatment for systemic lupus
Market availability of BPC-157 does not imply clinical safety, as materials intended for laboratory analysis are produced under different standards than those for human consumption. This synthetic pentadecapeptide, consisting of a sequence of fifteen amino acids, has become a prominent subject of
Baseline next-generation sequencing reveals that over 76 percent of lung cancer patients harbor additional genomic alterations that can shorten treatment durability. This statistic underscores the persistent challenge of managing advanced malignancies outside the sterile confines of traditional
Modern hydrogel designs mimic the natural environment of living tissue by maintaining a moisture content of roughly 90 percent to prevent cell death and scarring. This fundamental shift in wound management comes at a time when traditional methods are increasingly viewed as insufficient for the
